Insider Selling: Oscar Health (NYSE:OSCR) Insider Sells 7,338 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) insider Janet Liang sold 7,338 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $121,737.42. Following the sale, the insider directly owned 172,527 shares in the company, valued at $2,862,222.93. This trade represents a 4.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Oscar Health Price Performance

Shares of OSCR traded up $0.07 on Thursday, reaching $17.17. The stock had a trading volume of 7,737,399 shares, compared to its average volume of 14,589,062. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.80. The firm has a market capitalization of $4.55 billion, a PE ratio of -15.33 and a beta of 1.88. The firm has a 50-day moving average of $18.08 and a 200 day moving average of $16.93. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. The company had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.Oscar Health’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.22) earnings per share. Sell-side analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Institutional Investors Weigh In On Oscar Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Envestnet Asset Management Inc. grew its position in shares of Oscar Health by 200.9% in the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock valued at $648,000 after purchasing an additional 20,171 shares during the period. Nuveen LLC acquired a new stake in shares of Oscar Health in the first quarter worth approximately $29,684,000. NewEdge Advisors LLC boosted its position in shares of Oscar Health by 89.7% in the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company’s stock worth $2,465,000 after acquiring an additional 88,946 shares during the last quarter. Matauro LLC purchased a new stake in Oscar Health in the second quarter valued at approximately $1,508,000. Finally, Connor Clark & Lunn Investment Management Ltd. increased its position in Oscar Health by 19.0% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company’s stock worth $6,581,000 after purchasing an additional 79,979 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

OSCR has been the topic of a number of research reports. UBS Group increased their price objective on shares of Oscar Health from $11.00 to $12.00 and gave the company a “sell” rating in a research note on Friday, November 7th. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. Wells Fargo & Company lowered their price target on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, Barclays lifted their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research report on Monday, November 10th. One research analyst has rated the stock with a Buy rating, five have given a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Oscar Health presently has a consensus rating of “Reduce” and an average target price of $14.86.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.